Daratumumab: The perplexity in immunohematology with emerging horizons in myeloma therapy
CD38 is a disulfide-linked molecule present on red blood cells (RBCs) and daratumumab; an anti-CD38 monoclonal antibody is a novel agent for treating multiple myeloma patients. It also binds to the RBC along with the plasma cells in concern, creating a menace in the immunohematology workups and requ...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Asian Journal of Transfusion Science |
Subjects: | |
Online Access: | http://www.ajts.org/article.asp?issn=0973-6247;year=2020;volume=14;issue=2;spage=200;epage=202;aulast=Agrawal |